Effect of Low-dose ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Low Dose Trial.
Ramzi A TabbalatImad AlhaddadAyman HammoudehYousef Saleh KhaderHassan Abu KhalafMohammad ObaidatJude BarakatPublished in: The Journal of international medical research (2021)
Low-dose colchicine did not prevent POAF in patients undergoing cardiac surgery. These results should be interpreted cautiously because of the small sample size and early study termination.ClinicalTrials.gov Unique Identifier number: NCT03015831.
Keyphrases
- low dose
- atrial fibrillation
- high dose
- cardiac surgery
- minimally invasive
- patients undergoing
- end stage renal disease
- heart failure
- ejection fraction
- newly diagnosed
- chronic kidney disease
- acute kidney injury
- clinical trial
- peritoneal dialysis
- catheter ablation
- left atrial
- phase iii
- oral anticoagulants
- left atrial appendage
- percutaneous coronary intervention
- coronary artery disease
- direct oral anticoagulants
- phase ii
- mitral valve
- patient reported outcomes